21 CFR 862.1460
§ 862.1460 Leucine aminopeptidase test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1460, § 862.1460 Leucine aminopeptidase test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89135
- Permanent ID
ys:prov:89135@1- SHA-256
014ab8f52ece4fde9daf7394085fdda604491897ac8c70ccc18dd6888b9bd1e9
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A leucine aminopeptidase test system is a device intended to measure the activity of the enzyme leucine amino-peptidase in serum, plasma, and urine. Leucine aminopeptidase measurements are used in the diagnosis and treatment of liver diseases such as viral hepatitis and obstructive jaundice.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.